Diabetes & Metabolism Journal
Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na+-d-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine | ACS Omega
IJMS | Free Full-Text | Crosstalk between Sodium–Glucose Cotransporter Inhibitors and Sodium–Hydrogen Exchanger 1 and 3 in Cardiometabolic Diseases
Sodium–glucose cotransporters: Functional properties and pharmaceutical potential - Sano - 2020 - Journal of Diabetes Investigation - Wiley Online Library
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, in overweight/obese patients with type 1 diabetes: addressing unmet needs as adjunct therapy to insulin - Media Centre | EASD
Sodium Glucose Cotransporter Inhibitor - an overview | ScienceDirect Topics
SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives | Cardiovascular Diabetology | Full Text
Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus. - Abstract - Europe PMC
Preclinical and clinical SGLT1, SGLT2, and dual SGLT1/2 inhibitors. | Download Scientific Diagram
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials | The BMJ
Lexicon Fires Back after Sanofi Ends Up-to-$1.7B Diabetes Collaboration
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control | Nature Reviews Cardiology
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus | SpringerLink
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
Typ-1-Diabetes
Clinical Significance Of SGLT-2 | Our Biochemistry- Namrata Chhabra
Carbohydrates in medicines (SGLT-2 inhibitors for the treatment of type 2 diabetes mellitus)
24-week efficacy and safety of sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes (inTandem2) - Media Centre | EASD
SGLT inhibitors in management of diabetes - The Lancet Diabetes & Endocrinology
SGLT Inhibitors
Role and regulation of intestinal SGLT1 for glucose uptake and... | Download Scientific Diagram
Frontiers | New insights and advances of sodium-glucose cotransporter 2 inhibitors in heart failure
